Summary The aim of this investigation was to study whether certain bacteria could be used for cyanide degradation in soil. The bacteria Pseudomonas stutzeri and Bacillus subtilis were selected based on their good growth in a minimal medium containing 0.8 mg mL-1 potassium cyanide (KCN). In this study we tested their ability to reduce cyanide levels in a medium containing 1.5 mg mL-1 of KCN. Although both microorganisms reduced cyanide levels, Pseudomonas stutzeri was the more effective test organism. Later on, the selected cultures were grown, diluted and their various cell concentrations were used individually and in combination to test their ability of cyanide degradation in soil samples collected around a cassava processing mill. Bacillus subtilis caused degradation of soil cyanide from 0.218 mg g-1 soil immediately with an inoculum concentration of 0.1 (OD600nm) to 0.072 mg g-1 soil after 10 days with an inoculum concentration of 0.6 (OD600nm) implying a 66.9 % reduction. Pseudomonas stutzeri cell concentration of 0.1 (OD600nm) decreased soil cyanide from 0.218 mg g-1 soil initially to 0.061 mg g-1 soil after 10 days with an inoculum concentration of 0.6 (OD600nm) (72 % reduction). The mixed culture of the two bacteria produced the best degradation of soil cyanide from 0.218 mg g-1 soil sample with a combined inoculum concentration of 0.1 (OD600nm) initially to 0.025 mg g-1 soil with a combined inoculum concentration of 0.6 (OD600nm) after 10 days incubation resulting in an 88.5 % degradation of soil cyanide. The analysed bacteria displayed high cyanide degradation potential and may be useful for efficient decontamination of cyanide contaminated sites.
Background Rapid emergence of multidrug resistant Staphylococcus aureus has resulted to difficulty in treatment of infections caused by such strains. The aim of this meta-analysis study was to determine the pooled prevalence of resistance of S. aureus to different antibiotics in Nigeria. Methods Literature search for studies was done using Google scholar, PubMed, Science direct, and African Journal Online. The prevalence of S. aureus resistance to different antibiotics was evaluated using the meta-analysis proportion command in MedCalc software version 20.0 adopting a rand effect model. I2 statistic and Egger test in MedCalc was used to evaluate the heterogeneity and the presence of publication bias among studies respectively. Results A total of 40, 682 studies were retrieved through the database search of which 98 studies met the study inclusion criteria. Prevalence of resistance of S. aureus to different antibiotics ranges from 13 to 82%. Results showed a very high degree of resistance to penicillin G (82% [95% confidence interval (CI) 61%, 0.96%]), cloxacillin (77% [95% CI 64%, 88%]), amoxacillin (74% [95% CI 66%, 81%]), cefuroxime (69% [95% CI 51%, 85%]), ampicillin (68% [95% CI 53%, 81%]). Moderately resistance to erythromycin (47% [95% CI 40%, 53%]), chloramphenicol (47% [95% CI 37%, 56%]), methicillin (46% [95% CI 37%, 56%]), ofloxacin (24% [95% CI 18%, 31%]) and rifampicin 24% [95% CI 6%, 48%]). Low resistance was observed in vancomycin 13% (95% CI 7%, 21%). For each individual meta-analysis, high heterogeneity was observed with I2 range (79.36–98.60%) at p-values ≤ 0.01). Egger’s tests for regression intercept in funnel plots indicated no evidence of publication bias. Conclusion This meta-analysis study established that S. aureus in Nigeria has developed resistance to commonly used antibiotics such as the beta-lactam class antibiotics, sulphonamides, tetracyclines, chloramphenicol, and vancomycin. Hence it is imperative to develop programs to promote rational use of antimicrobial agents, infection prevention and control to reduce the incidence of antimicrobial resistance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.